Active Ingredient History

  • Now
Idursulfase, manufactured by Takeda, is a drug used to treat Hunter syndrome. It is a purified form of the lysosomal enzyme iduronate-2-sulfatase and is produced by recombinant DNA technology in a human cell line.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$2320.4100 - $2900.2600
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

alpha-l-iduronate sulfate sulfatase | ec | elaprase | gsk2788723 | iduronate 2-sulfatase | iduronate-2-sulfatase | iduronate sulfatase | idursulfase | idursulfase beta | idursulfase (genetical recombination)


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue